Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.52 |
| ▸ | PPARG | P37231 | 2/20 | 0.52 |
| ▸ | PPARD | Q03181 | 2/20 | 0.52 |
| ▸ | PPARA | Q07869 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
| ▸ | TLR2 | O60603 | 1/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2989445 | 0.98 | CES2 (0.64) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL11509841 | 0.98 | CES2 (0.64) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL7915536 | 0.93 | CES2 (0.52) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL26131543 | 0.88 | CES2 (0.54) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL7915761 | 0.88 | CES2 (0.48) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL9936167 | 0.87 | FAAH (0.55) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL10589346 | 0.86 | CES2 (0.57) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL8637203 | 0.86 | CES2 (0.57) | CES2MEN1KMT2AGPR84PPARG | |
| SCHEMBL7307626 | 0.86 | CES2 (0.57) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL10360944 | 0.86 | CES2 (0.57) | CES2MEN1KMT2AGPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2476715-B1 | Polymer compound, luminescent material, and light emitting element | SUMITOMO CHEMICAL CO (JP) | 2018-11-14 | — | — | EP | disclosed |
| EP-1932851-B1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL CO (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2476715-A2 | Polymer compound, luminescent material, and light emitting element | Sumitomo Chemical Co., Ltd (JP) | 2012-07-18 | — | — | EP | disclosed |
| EP-1935943-B1 | POLYMER COMPOUND, LUMINESCENT MATERIAL, AND LIGHT EMITTING ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2012-03-28 | — | — | EP | disclosed |
| US-20100264812-A1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-1935943-A1 | POLYMER COMPOUND, LUMINESCENT MATERIAL, AND LIGHT EMITTING ELEMENT | Sumitomo Chemical Company, Limited (JP) | 2008-06-25 | — | — | EP | disclosed |
| EP-1932851-A1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | Sumitomo Chemical Company, Limited (JP) | 2008-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100264812-A1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | SOD1, CRY1, YAP1 | CES2 4867/4885MEN1 993/4885FAAH 4188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.